Results 91 to 100 of about 409 (115)

[18F]FDG-PET and [18F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation. [PDF]

open access: yesSci Rep
Day I   +8 more
europepmc   +1 more source

Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. [PDF]

open access: yesSci Adv
McGivney GR   +16 more
europepmc   +1 more source

l-arginine:glycine amidinotransferase (AGAT) deficiency: Clinical presentation and response to treatment in two patients with a novel mutation

open access: yesMolecular Genetics and Metabolism, 2010
Creatine and creatine phosphate provide storage and transmission of phosphate-bound energy in muscle and brain. Of the three inborn errors of creatine metabolism causing brain creatine depletion, l-arginine:glycine amidinotransferase (AGAT) deficiency has been described in only two families.
Simon Edvardson   +2 more
exaly   +4 more sources

Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide [PDF]

open access: yesMolecular Genetics and Metabolism, 2015
Arginine:glycine aminotransferase (AGAT) (GATM) deficiency is an autosomal recessive inborn error of creative synthesis. We performed an international survey among physicians known to treat patients with AGAT deficiency, to assess clinical ...
Sylvia Stöckler-Ipsiroglu   +2 more
exaly   +3 more sources

Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: Early treatment can prevent phenotypic expression of the disease [PDF]

open access: yesJournal of Pediatrics, 2006
Arginine:glycine amidinotransferase deficiency is a treatable inborn error of creatine synthesis, characterized by mental retardation, language impairment, and behavioral disorders.
Roberta Battini   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy